Author

Karen Woolley

Observed name: K J Woolley

Institution: Multiple Myeloma Research Foundation

Observed institutions: Memorial Sloan Kettering Cancer Center, Cornell University, Multiple Myeloma Research Foundation

OpenAlex ID: A5028090131

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.

1994 · P A Francis, J R Rigas, et al. · Journal of Clinical Oncology · 216

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer

1995 · Vincent A. Miller, James R. Rigas, et al. · Cancer · 120

The Mydrug Platform Trial: Efficacy and Safety of Daratumumab, Ixazomib, Pomalidomide, and Dexamethasone in Patients with Functionally High-Risk Multiple Myeloma

2022 · Shaji K Kumar, Craig C Hofmeister, et al. · Blood · 3

Phase 2 Trial of Pomalidomide, Ixazomib and Dexamethasone in Patients with Multiple Myeloma with Extramedullary Disease or Plasma Cell Leukemia

2020 · Francis K. Buadi, Martha Q. Lacy, et al. · Blood · 2

Works count: 4

Citation count: 341

H-index: 3

I10-index: 2